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In the types of multiple endocrine neoplasia (MEN), type 1 means involvements of the 
ar附町pituitary,parathyroid gland and/or the islet of the pancreas. Among these neoplasias, 
pancreatic lesions are most important because the prognosis of patients depends on the progression 
of hormone-producing islet-cell tumors. Although Zollinger Ellison syndrome due to gastrinoma 
and hyperinsulinism are most prevalent, nonfunctioning or asymptomatic islet cell tumors of 
the pancreas are occasionally noted. 
A case of 40-year-old female developing five benign tumors of the islet of pancreas was re-
port疋d. The hormonal assay revealed that the patient had asymptomatic or nonfunctioning 
tumors. Enucleation of each tumors was performed, and the results were satisfactory. 
Key words: Multiple endocrine neoplasia (MEN), MEN type 1, Nonfunctioning (asymptomatic) multiple islet-
cel tumors of the pancreas, Enucleation of multiple islet-cel tumors, Postoperative pancreatic fistula. ：~~：多内分糊腫場症， MEN 第 1型，淵能性（無症候酌多発勝島醐，多発勝島醐核出術，術後障




endocrine neoplasia or adenornatosis (MEN or MEA) 
などといわれる病態は，多内分泌腺腫湯の発生部位lζ














































Table 1. Preoperative laboratory data of endocrine function 
Serum 
Se cretin 140 pg/ml TSH 6.3 rnicroU/rnl 
Gastrin 71 pg/ml Cortisol 6.6 rnicrog/dl 
Sornatostatin 14.5 pg/ml Aldosterone 82 pg/ml 
Glucagon 100 pg/ml 
Urine 
Carctionin 84 pg/ml 
Cathecolamine 134.5 microg/day 
PTH-C 0.23 ng-E/ml 
Adrenaline 10.1 microg/day c . 10.6 mg/di 
Noradrenaline 124.4 microg/day 
Elastase-I 330 ng/dl 
17-0HCS 6.1 mg/day 
HGH 1.5 ng/ml 
17-KGS 11.2 mg/day 
Prolactin 25.7 ng/ml 
17-KS 6.4 mg/day 
ACTH 25 pg/ml 
C-peptide 72 microg/day 
LH 9.lrnIU/ml 
Estrogen 38.6 microg/day 
FSH 9.5mIU/ml 一一一←一一一一一一一一
Ta-RSU 29.4% 0・GTT;normal, IRI; transiently 
T. 8.4 microg/dl high, Pituitary hormone releasing 
FTI 2.47 ng/dl tests; within normal range 
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Fig. 1. CT of the abdomen showing multiple pancreatic mass 
Fig. 2. CT of the pituitary川 lt・nnrnけ
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Fig. 3. Allows in the ERP showing decompression 。fthe main pancreatic duct 
施行した．各腫痛とも被膜を有しており，各摘出部は
死膝形成のないように出来得る限り縫合閉鎖した．























Fig. 4. Multiple pancreatic tumors visualized in celiac angiography 
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従来 Pearse附の APUD(amine content and/or 
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Fig. 9. Postoperative ERP showing the smooth 
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